6/9/26 16:53 | 6/5/26 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | TX | T | | 1 | P.d | 100 | 0.4500 | 0 | 222 | 6 | 4,053 | I | | | | | | | | | | | | | | |
6/9/26 16:20 | 6/8/26 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kumar Rashmi | UT | D | | 1 | S | -67 | 4.46 | 0 | -15 | | 172 | D | | | | | | | | | | | | | | |
6/2/26 17:00 | 6/1/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | 1 | M.d | 0 | 0.00 | 0 | 1 | 7 | 10 | D | | | | | | | | | | | | | | |
5/29/26 16:05 | 9/17/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fraser John D | TX | D | | 1 | P.ad | 7 | 0.4500 | 0 | 16 | 2 | 854 | D | | | | | | | | | | | | | | |
5/29/26 16:05 | 9/17/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cohen Jeffrey K | TX | D | | 1 | P.ad | 25 | 0.4500 | 0 | 56 | 14 | 446 | D | | | | | | | | | | | | | | |
5/19/26 08:37 | 5/18/26 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | Former G | 1 | M.d | 327 | 9.29 | 0 | 35 | 75 | 82 | D | | | | | | | | | | | | | | |
5/14/26 17:33 | 3/30/26 | QCLS | Q/C Technologies, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Voss Chelsea Sierra | NY | D | | 1 | P | 6 | 3.15 | 0 | 2 | 1 | 301 | I | | | | | | | | | | | | | | |
5/14/26 17:16 | 5/14/26 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bisaro Paul | UT | D | | 1 | P | 28 | 3.69 | 0 | 8 | 8 | 97 | D | | | | | | | | | | | | | | |
5/11/26 17:11 | 5/7/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | 3 | 9 | D | | | | | | | | | | | | | | |
5/11/26 17:10 | 5/7/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Peacock Karen | ME | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | 999% | 0 | D | | | | | | | | | | | | | | |
5/11/26 17:10 | 5/7/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Lawrence D | ME | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | 4 | 10 | D | | | | | | | | | | | | | | |
5/11/26 17:10 | 5/7/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | 8 | 4 | D | | | | | | | | | | | | | | |
5/11/26 17:10 | 5/7/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hooley Joseph L | ME | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | 134 | 0 | D | | | | | | | | | | | | | | |
5/5/26 10:06 | 5/4/26 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Moylan John Patrick | MI | O | Chief Ac | 1 | M.d | 43 | 9.53 | 0 | 5 | 36 | 17 | D | | | | | | | | | | | | | | |
4/27/26 19:08 | 4/23/26 | IMDX | Insight Molecular Diagnostics Inc. | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | 2 | P.dm | 2,685 | 3.57 | 0 | 753 | 3 | 25,370 | M | | | | | | | | | | | | | | |
3/30/26 17:29 | 3/26/26 | IMDX | Insight Molecular Diagnostics Inc. | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | TN | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 28 | 16 | 206 | D | | | | | | | | | | | | | | |
3/30/26 17:29 | 3/26/26 | IMDX | Insight Molecular Diagnostics Inc. | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Liu James Yang | TN | O | VP ACCT, | 1 | M.d | 0 | 0.00 | 0 | 6 | | 4 | D | | | | | | | | | | | | | | |
3/30/26 17:29 | 3/26/26 | IMDX | Insight Molecular Diagnostics Inc. | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | TN | DO | CEO,P | 1 | M.d | 0 | 0.00 | 0 | 47 | | 38 | D | | | | | | | | | | | | | | |
3/24/26 19:57 | 3/20/26 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Brigham Michael F | ME | D | | 1 | M.d | 146 | 5.84 | 0 | 25 | 14 | 206 | D | | | | | | | | | | | | | | |